Portfolio Lab

BlackRock Health Sciences Term Trust

  • Stock
  • Ticker BMEZ
  • NYSE

Performance, volatility and drawdowns of BlackRock Health Sciences Term Trust since 01/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

1-year return
+18.0%
5-year return p.a.
+0.7%
Return p.a. since 01/2020
+5.8%
Volatility p.a.
20.3%
Largest decline
−46.2%

Performance

BMEZGlobal equities (VT)

$10,000 grew to $10,039. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −46.2% in 05/2022, measured from the peak in 02/2021. It took 68 months to get back to the old peak.

Annual returns

Best year 2025 at +18.7%, weakest 2022 at −32.6%. 3 of 5 full years were positive. * partial year.

Compared with Global equities

Since 01/2020BMEZGlobal equities (VT)
Return p.a.+5.8%+10.7%
Volatility p.a.20.3%16.7%
Largest decline−46.2%−34.2%
Return per unit of risk0.280.64
$10,000 grew to$14,634$19,960

Bold: the better value in each row. Return per unit of risk: return p.a. divided by volatility p.a. Correlation of monthly returns with Global equities: 0.76 (1 would mean they moved in lockstep).

More stocks of similar size

Test BMEZ in your own portfolio

Mix it with other securities, set recurring investments and costs, compare against a broad equity ETF. No account needed.

Open in backtest

Frequently asked questions

How has BMEZ performed since 01/2020?

$10,000 grew to $14,634 by 20 Nov 2026, which is +5.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BMEZ?

Volatility was 20.3% per year, measured on monthly returns. The largest decline from a peak was −46.2%, with the low in 05/2022.

How does BMEZ compare with a broad equity ETF?

Over the same period Global equities (VT) returned +10.7% per year at 16.7% volatility, BMEZ returned +5.8% at 20.3%. The correlation of monthly returns was 0.76; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.